nafazatrom has been researched along with d-alpha tocopherol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brezová, V; Misík, V; Ondrias, K; Stasko, A | 1 |
| Gergèl, D; Hromadová, M; Ondrias, K; Ondriasovà, E; Stasko, A | 1 |
2 other study(ies) available for nafazatrom and d-alpha tocopherol
| Article | Year |
|---|---|
Reaction kinetics of alpha-tocopheroxyl radical with biologically and pharmacologically active substances.
Topics: Antioxidants; Carbolines; Electron Spin Resonance Spectroscopy; Epinephrine; Free Radicals; Histamine; Isoproterenol; Kinetics; Lipoxygenase Inhibitors; Mathematics; Models, Theoretical; Oxidation-Reduction; Pyrazoles; Pyrazolones; Time Factors; Vitamin E | 1993 |
Nafazatrom inhibits peroxidation of phosphatidylcholine liposomes, heart homogenate and low density lipoproteins.
Topics: Animals; Antioxidants; Electron Spin Resonance Spectroscopy; Fibrinolytic Agents; Heart; Humans; Lipid Peroxidation; Lipoproteins, LDL; Liposomes; Myocardium; Phosphatidylcholines; Pyrazoles; Pyrazolones; Rats; Vitamin E | 1997 |